Loosen, S. H., Schulze‐Hagen, M., Vucur, M., Gorgulho, J., Paffenholz, P., Benz, F., . . . Roderburg, C. (2021). Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis. JGH Open.
Style de citation ChicagoLoosen, Sven H., et al. "Elevated Soluble Urokinase Plasminogen Activator Receptor Serum Levels Indicate Poor Survival Following Transarterial Chemoembolization Therapy for Hepatic Malignancies: An Exploratory Analysis." JGH Open 2021.
Style de citation MLALoosen, Sven H., et al. "Elevated Soluble Urokinase Plasminogen Activator Receptor Serum Levels Indicate Poor Survival Following Transarterial Chemoembolization Therapy for Hepatic Malignancies: An Exploratory Analysis." JGH Open 2021.